Abstract
A new trehalose analog, lentztrehalose [4-O-(2,3-dihydroxy-3-methylbutyl) trehalose], was isolated from an actinomycete Lentzea sp. Lentztrehalose is only weakly hydrolyzed by the trehalose-hydrolyzing enzyme, trehalase, so can be regarded as an enzyme-stable analog of trehalose. Although lentztrehalose does not show apparent toxicity to mammalian cells and microbes, it has antitumor activity in mice bearing S-180 sarcoma and Ehrlich carcinoma cells. In ovariectomized mice, lentztrehalose displayed a bone reinforcement effect in the femur that was superior to trehalose and induced non-morbid suppression of weight gain comparable with trehalose. These results indicate that enzyme-stable analogs of trehalose, such as lentztrehalose, may be more beneficial for human health and thus have potential as substitutes for trehalose as a sweetener. © 2014 Japan Antibiotics Research Association. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Wada, S. I., Ohba, S. I., Someno, T., Hatano, M., & Nomoto, A. (2014). Structure and biological properties of lentztrehalose: A novel trehalose analog. Journal of Antibiotics, 67(4), 319–322. https://doi.org/10.1038/ja.2013.143
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.